Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, L

Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

The Europe enteral and parenteral medical nutrition market is expected to grow from US$ 6,472.35 million in 2023 to US$ 9,054.89 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.

Increasing Cases of Malnutrition and Premature Births Fuels Europe Enteral and Parenteral Medical Nutrition Market

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. According to a Specialized Nutrition Europe study, nearly 40% of hospitalized adult patients were malnourished in Europe in 2019. Nutritional support delivered through enteral & parenteral means, depending on the need, is an important and appropriate way of treating most malnutrition cases. Thus, the huge burden of malnutrition in children and adults drives the demand for enteral and parenteral nutrition formulae and products. Preterm birth refers to a baby being born too early, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm birth (more than 1 in 10 births) were reported worldwide in 2020. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe, also parenteral nutrition is preferred in such babies due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. Hence, with the high number of preterm births, the demand for enteral and parenteral medical nutrition is on the rise in the region.

Europe Enteral and Parenteral Medical Nutrition Market Overview

The Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Europe occupies a significant position in the Europe enteral and parenteral medical nutrition market and is estimated to register a robust growth rate over the forecast period. The market growth can be attributed to increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region.

Europe Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

Europe Enteral and Parenteral Medical Nutrition Market Segmentation

The Europe enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.

Based on indication, the Europe enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.

Based on nutrition type, the Europe enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on form, the Europe enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on product type, the Europe enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on route of administration, the Europe enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on age group, the Europe enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023.

Based on distribution channel, the Europe enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the Europe enteral and parenteral medical nutrition market in 2023

Based on country, the Europe enteral and parenteral medical nutrition market is segmented into Germany, the UK, France, Italy, Spain, Poland, Switzerland, Sweden, Belgium, the Netherlands, and the Rest of Europe. Germany dominated the share of the Europe enteral and parenteral medical nutrition market in 2023.

Abbott Laboratories; AYMES International Ltd; B. Braun SE; Baxter International Inc; Charing Cross Scientific AS; Fresenius Kabi AG; Medifood International SA; Nestle SA; Nutricia International BV; and Smartfish AS are some of the leading companies operating in the Europe enteral and parenteral medical nutrition market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enteral and parenteral medical nutrition market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.